By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences has issued a call notice to holders of its outstanding warrants, the firm said in a filing with the US Securities and Exchange Commission today.

The firm said that each outstanding warrant will continue to be exercisable for preferred stock at an exercise price of $12.50 per share until the close of business on April 27, 2010. On April 28, 2010, any unexercised warrants will be terminated and no longer be exercisable, according to the company.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.